Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to DEPRESSION

British Medical Journal

Comparative Oral Monotherapy of Psilocybin, Lysergic Acid Diethylamide, 3,4-methylenedioxymethamphetamine, Ayahuasca, and Escitalopram for Depressive Symptoms

Psychiatry September 10th 2024

Psych Congress Network

Clinician-Level Differences Significantly Affect MDD Prescribing, Outcomes

Psychiatry August 14th 2024

The New England Journal of Medicine

Depression — Advanced Treatments for Treatment-Resistant Depression

Psychiatry June 4th 2024

MDLinx

FDA Approves Depression-treating Phone App

Psychiatry May 28th 2024

Psychiatry Advisor

Ketamine vs ECT: Which Therapy is More Effective for Depression?

Psychiatry May 21st 2024

Psychiatry Advisor

Adjunctive Antipsychotic Therapies in the Treatment of Major Depressive Disorder

Psychiatry May 7th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form